Recommended Design Features of Future Clinical Trials of Antibacterial Agents for Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia
Open Access
- 1 August 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 51 (S1), S150-S170
- https://doi.org/10.1086/653065
Abstract
The efficacy of new antibacterial agents for the treatment of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) has typically been compared with that of established antibacterial agents in noninferiority clinical trials. However, the US Food and Drug Administration (FDA) has reevaluated the appropriateness of noninferiority trial designs for a variety of diseases, including HAP and VAP. The resulting regulatory uncertainty regarding appropriate trial design is an important barrier to the development of new antibacterial agents.This publication has 89 references indexed in Scilit:
- Hospital‐Acquired Pneumonia, Health Care–Associated Pneumonia, Ventilator‐Associated Pneumonia, and Ventilator‐Associated Tracheobronchitis: Definitions and Challenges in Trial DesignClinical Infectious Diseases, 2010
- Use of Severity Scoring and Stratification Factors in Clinical Trials of Hospital‐Acquired and Ventilator‐Associated PneumoniaClinical Infectious Diseases, 2010
- The “Zero Risk” Concept for Hospital‐Acquired Infections: A Risky Business!Clinical Infectious Diseases, 2009
- Antimicrobial Agents for Complicated Skin and Skin‐Structure Infections: Justification of Noninferiority Margins in the Absence of Placebo‐Controlled TrialsClinical Infectious Diseases, 2009
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Issues in Noninferiority Trials: The Evidence in Community‐Acquired PneumoniaClinical Infectious Diseases, 2008
- Executive Summary: Workshop on Issues in the Design and Conduct of Clinical Trials of Antibacterial Drugs in the Treatment of Community‐Acquired PneumoniaClinical Infectious Diseases, 2008
- Predictive Value of Broncho-Alveolar Lavage Fluid Gram’s Stain in the Diagnosis of Ventilator-Associated Pneumonia: A Prospective StudyThe Journal of Trauma and Acute Care Surgery, 2008
- A Step Closer to Extreme Drug Resistance (XDR) in Gram-Negative BacilliClinical Infectious Diseases, 2007
- Multidrug-resistantAcinetobacterInfection Mortality Rate and Length of HospitalizationEmerging Infectious Diseases, 2007